Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures (PREV-URG)
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Studieoversikt
Status
Forhold
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Christelle JADEAU
- Telefonnummer: +332 44 71 07 81
- E-post: cjadeau@ch-lemans.fr
Studer Kontakt Backup
- Navn: Cyrielle HOUALARD, MD
- Telefonnummer: +332 43 43 43 43
- E-post: choualard@ch-lemans.fr
Studiesteder
-
-
Sarthe
-
La Flèche, Sarthe, Frankrike, 72205
- Pôle Santé Sarthe et Loir
-
Ta kontakt med:
- Cyrielle HOUALARD, MD
- Telefonnummer: +332 44 71 30 00
- E-post: choualard@ch-lemans.fr
-
Le Mans, Sarthe, Frankrike, 72000
- Centre Hospitalier du Mans
-
Ta kontakt med:
- Cyrielle HOUALARD, MD
- Telefonnummer: +332 43 43 43 43
- E-post: choualard@ch-lemans.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Exclusion Criteria:
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
- Individuals receiving involuntary psychiatric care
- Individuals subject to a legal protective measure
- Pregnant or breastfeeding patients.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: A - Intervention
The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them.
|
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
|
|
Eksperimentell: B - Control
The second "control" group, designated B, receives non-personalized information.
Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
The intervention involves providing non-personalized preventive health information.
The patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
proportion of patients who adhered to at least 25% of the preventive measures
Tidsramme: 6-8 weeks after the intervention.
|
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term |
6-8 weeks after the intervention.
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The proportion of patients who adhered to each of the preventive measures studied.
Tidsramme: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Tidsramme: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Tidsramme: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- CHM-2025/S02/17
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .